Hanoi, January 22 (VNA) – Vietnam encourages international pharmaceutical businesses, including members of EuroCham, to extend their investment and establish research centres in the country, said Nguyen Van Binh, Secretary of the Party Central Committee and head of the committee’s Economic Commission.
At a reception for a delegation of the European Chamber of Commerce in Vietnam (EuroCham)’s Pharmaceutical Sector Committee (Pharma Group) in Hanoi on June 22, Binh said that Vietnam attaches importance to implementing social policies comprehensively and pays attention to providing easy access to health care services and medicines at reasonable prices.
Binh briefed the delegation on major orientations and solutions of the Vietnamese Party and Government in order to improve business environment, raise competiveness and encourage enterprises to roll out their operation on a larger scale, particularly in the pharmaceutical sector. He added that Vietnam wants to become a pharmaceutical production centre in ASEAN.
Pharma Group Vice President Nicholas Jones, who is in charge of the Vietnamese market, expressed his optimism about Vietnam’s socio-economic development prospects as well as the country’s policies and measures to improve business climate.
He spoke about challenges facing the pharmaceutical and health care sector, saying he hopes that Vietnam will make more improvements in legal framework, mechanisms and policies, to better accommodate firms operating in pharmaceutical industry.
The participating businesses shared the views that Vietnam is an important market and has potential to become a pharmaceutical production centre of ASEAN.
They also talked about pharmaceutical development models and sustainable access to medicines of people, along with issues regarding Government bidding and procurement, property rights and investment opportunities in Vietnam.
At a reception for a delegation of the European Chamber of Commerce in Vietnam (EuroCham)’s Pharmaceutical Sector Committee (Pharma Group) in Hanoi on June 22, Binh said that Vietnam attaches importance to implementing social policies comprehensively and pays attention to providing easy access to health care services and medicines at reasonable prices.
Binh briefed the delegation on major orientations and solutions of the Vietnamese Party and Government in order to improve business environment, raise competiveness and encourage enterprises to roll out their operation on a larger scale, particularly in the pharmaceutical sector. He added that Vietnam wants to become a pharmaceutical production centre in ASEAN.
Pharma Group Vice President Nicholas Jones, who is in charge of the Vietnamese market, expressed his optimism about Vietnam’s socio-economic development prospects as well as the country’s policies and measures to improve business climate.
He spoke about challenges facing the pharmaceutical and health care sector, saying he hopes that Vietnam will make more improvements in legal framework, mechanisms and policies, to better accommodate firms operating in pharmaceutical industry.
The participating businesses shared the views that Vietnam is an important market and has potential to become a pharmaceutical production centre of ASEAN.
They also talked about pharmaceutical development models and sustainable access to medicines of people, along with issues regarding Government bidding and procurement, property rights and investment opportunities in Vietnam.
VNA/VNP
